The most played episodes among Podcast App listeners.

1. 1
   Number 1: Poo transplant shows promise as treatment for peanut allergy

   In the news:In a small study, participants with a peanut allergy swallowed capsules containing treated faecal matter, and tried a dose of peanut four months later. Some were able to tolerate the peanut without a reaction.CEO of Eli Lilly discusses barriers to getting their GLP-1 agonist medication listed on the PBS, and questions the veracity of the process for getting the most up to date medications to Australian patients.The President of the United States signed an executive order changing the childhood vaccine schedule, making a link to autism, despite evidence to the contrary.ReferencesNature: First poo transplant to treat food allergy in people has ‘exciting’ resultsEli Lilly CEO still wants deal to bring Mounjaro to Australia under PBSTrump signs order to reduce childhood vaccines and break up MMR shots

   August 14, 2026·13min
   Play
2. 2
   Number 2: Why is it so easy to get weight loss injections, if they could cause you harm?

   ‘Kate’ has a history of anorexia nervosa and was once hospitalised for the condition. Yet she was able to access GLP1s to control her weight via a telehealth provider, without being screened for an eating disorder. She says it was “criminally easy” and is speaking out to protect others. While Australian data on this issue is not yet published, a study from the United States shows a person with an eating disorder is twice as likely as someone without one, to access GLP1s for weight loss. According to their data, one in five people with eating disorders in the study were currently using them. An Australian clinical psychologist and expert says awareness of the need for eating disorder screening amongst general practitioners is patchy and that more needs to be done to educate about the risks of prescribing weight loss injections to patients. If you or anyone you know needs help with an eating disorder: Butterfly Foundation on 1800 334 673National Eating Disorder CollaborationLifeline on 131 114 Guest/s‘Kate’ person with lived experience of anorexia nervosa Dr Cheri Levinson, Professor in the Department of Psychological and Brain Sciences, University of Louisville and Director of the Eating Anxiety Treatment (EAT) labDr Nicholas Peiper, Professor, Epidemiology & Population Health, and Chief Scientist, Eating Anxiety Treatment (EAT) Laboratory, Department of Psychological & Brain Sciences, University of LouisvilleDr Sarah Trobe, clinical psychologist and National Director of the National Eating Disorder Collaboration (NEDC) ReferencesAHPRA statement on Telehealth providersJAMA Psychiatry: Use and Misuse of GLP-1 Receptor Agonists Among People With Eating Disorders

   August 07, 2026·25min
   Play
3. 3
   Number 3: Acute pancreatitis is becoming more common in younger people

   Surveys of acute pancreatitis are currently underway around Australia, in response to an increase in cases globally. A study from South Australia shows some surprising results with an increased incidence in young people, women and those from a higher socio-economic background. Guest/sGeorge Baretto, Professor of Surgery, College of Medicine and Public Health, Flinders University ReferencesEpidemiological time trends in acute pancreatitis – A 16-year experience from South Australia

   August 07, 2026·7min
   Play
4. 4
   Number 4: Mailbag: blood test for Alzheimer's disease diagnosis

   A look at some of the Health Report correspondence this week. You can email us at [email protected]

   August 07, 2026·8min
   Play
5. 5
   Number 5: New Ebola vaccine ready for testing on humans

   In the news:The same team who developed the first vaccine against COVID-19 have come up with a vaccine for the new strain of Ebola in only eight weeks.A report from the Grattan Institute calls for a shake-up of community pharmacy fundingUS Department of War head Pete Hegseth announces plans for testosterone screening for militaryReferencesUK begins trials of Ebola vaccine developed in just eight weeksFuture pharmacy: A better deal for patients and taxpayersPete Hegseth announces plan to test US troops for low testosterone

   July 17, 2026·9min
   Play